May 5, 2025- Abbott and MotoAmerica, the premier motorcycle road racing series in North America, announced that MotoAmerica is the first professional sports organization worldwide to use Abbott’s groundbreaking blood test to help assess suspected concussions for riders in the on-site medical facilities at all races.
Abbott’s test, the i-STAT TBI test cartridge, is used to evaluate patients 18 years of age and older who present with suspected mild traumatic brain injury (mTBI). It provides results in 15 minutes and may be used up to 24 hours after injury to help determine the need for a CT scan of the head. In 2024, Abbott’s i-STAT TBI test received clearance from the U.S. Food and Drug Administration (FDA) to be used with whole blood, allowing doctors to quickly assess patients with suspected mTBI onthe handheldi-STAT Alinityanalyzer at the patient’s side.